* Hologic Inc HOLX.OQ reported quarterly adjusted earnings
of
$1.01 per share for the quarter ended January 1, higher than
the same quarter last year, when the company reported EPS of 89
cents. The mean expectation of sixteen analysts for the quarter
was for earnings of $1.01 per share. Wall Street expected
results to range from 99 cents to $1.03 per share.
* Revenue rose 4.5% to $987.90 million from a year ago;
analysts
expected $976.69 million.
* Hologic Inc's reported EPS for the quarter was 76 cents.
* The company reported quarterly net income of $178.6
million.
* Hologic Inc shares had risen by 2.8% this quarter and
gained 17.2% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 0.1%
in the last three months.
* In the last 30 days, one analyst negatively revised an
earnings
estimate
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 11 "strong buy" or "buy," 9
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for Hologic Inc is
89.62
This summary was machine generated from LSEG data November 5 at
07:41 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 1.01 1.01 Met
Jun. 30 2024 1.02 1.06 Beat
Mar. 31 2024 0.98 1.03 Beat
Dec. 31 2023 0.95 0.98 Beat